| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/11/1992 | CA2088360A1 Quantitative analysis and monitoring of protein structure by substractive chromatography |
| 02/11/1992 | CA2048899A1 Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment |
| 02/11/1992 | CA1295785C Process for the preparation of aspartame and agents for carrying it out |
| 02/10/1992 | CA2023020A1 Carboxyl terminal peptide and protein sequencing |
| 02/08/1992 | CA2047902A1 Chromatography cartridge |
| 02/06/1992 | WO1992001938A1 Derivatization of c-terminal proline |
| 02/06/1992 | WO1992001708A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001692A1 Method for preparing sulphonylpristinamycin ii¿b? |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/06/1992 | CA2086923A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/05/1992 | EP0469985A1 Process for manufacturing von Willebrand factor having a very high purity |
| 02/05/1992 | EP0191772B1 Acid-cleavable compound |
| 02/04/1992 | US5086167 Method of separating proteins |
| 02/04/1992 | US5086164 Novel methods and compositions for treatment of angiogenic diseases |
| 02/04/1992 | US5086042 Capable of stimulating contraction of gall bladder; having six to nine amino acids with sulfonated tyrosine and C-terminal amides; treating obesity |
| 02/04/1992 | US5085749 Dynamically controlled membrane |
| 02/04/1992 | CA1295241C Lymphokine and its production and uses |
| 02/03/1992 | CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/02/1992 | WO1992002540A1 Method for purifying a protein present in an inclusion body |
| 02/02/1992 | CA2066598A1 Process for the purification of a protein in inclusion bodies |
| 02/01/1992 | WO1992002545A1 Bombesin antagonists |
| 02/01/1992 | CA2088166A1 Peptides |
| 01/30/1992 | DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies |
| 01/29/1992 | EP0468714A2 Peptide-polysaccharide-protein conjugate vaccines |
| 01/29/1992 | EP0468497A2 Peptide-antagonists of bombesin/GRP |
| 01/29/1992 | EP0468181A2 Process for the purification of factor VIII and factor VIII obtained by said process |
| 01/29/1992 | EP0467992A1 Process for purifying a protein |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | CN1058149A Stabilized fibroblast growth factor composition |
| 01/28/1992 | US5084559 Protein a domain mutants |
| 01/28/1992 | US5084184 Providing in a column a bed of magnetizable adsorbent solids, flowing fluid to a focusing zone |
| 01/28/1992 | CA1295087C Purification of recombinant beta-interferon incorporating rp-hplc |
| 01/28/1992 | CA1295086C 4-aminobutanoic acid derivatives, process of preparation and usethereof |
| 01/28/1992 | CA1295085C Heptanoyl-glu-asp-ala-amino acid immunostimulants |
| 01/28/1992 | CA1294901C Monoclonal antibody specific for human colon fibroblast-derived t-pa |
| 01/25/1992 | WO1992001790A1 Endogenously sweetened transgenic plant products |
| 01/25/1992 | WO1992001712A1 Analogs of hirudin |
| 01/25/1992 | WO1992001709A1 Process for synthesizing peptides |
| 01/25/1992 | CA2086416A1 Process for synthesizing peptides |
| 01/25/1992 | CA2066749A1 Analogs of hirudin |
| 01/23/1992 | WO1992001059A1 Cdr grafted anti-cea antibodies and their production |
| 01/23/1992 | WO1992001054A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 01/23/1992 | WO1992000994A1 Growth-promoting agent |
| 01/23/1992 | WO1992000993A1 Isolation and purification of lung surfactant protein |
| 01/23/1992 | WO1992000954A1 Aspartic protease inhibitors |
| 01/23/1992 | WO1992000950A1 A process for the preparation of alpha-l-aspartyl-l-phenylalanine methyl ester hydrochloride by use of isolated n-formyl l-aspartic anhydride |
| 01/23/1992 | WO1992000948A1 Inhibitors of retroviral proteases |
| 01/23/1992 | DE4124058A1 Glyco haemoglobin measurement by HPLC - by simultaneously sepg. glyco haemoglobin, haemoglobin and haemoglobin derivs. and removing labile haemoglobin to measure stable haemoglobin |
| 01/22/1992 | EP0467701A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467700A2 Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties |
| 01/22/1992 | EP0467699A2 Cyclic HIV principal neutralizing determinant peptides |
| 01/22/1992 | EP0467536A2 Method of treating bladder cancer cells |
| 01/22/1992 | EP0467339A1 Water-swellable crosslinked polymer particles and process for their production |
| 01/22/1992 | EP0466966A1 Synthetic chondroitin sulfate proteoglycan and process for producing the same |
| 01/22/1992 | EP0466963A1 A process for the preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride by use of isolated N-formyl-aspartic anhydride |
| 01/22/1992 | EP0466780A1 Megakaryocyte growth promoting activity |
| 01/22/1992 | EP0432218A4 Method for detecting cellular pathology |
| 01/22/1992 | CN1058022A Method for preparing interferon alpha-2 crystals |
| 01/21/1992 | US5082967 Novel fatty acid analog enzyme substrates |
| 01/21/1992 | US5082775 Prochymosin, making cheese |
| 01/21/1992 | US5082767 Codon pair utilization |
| 01/21/1992 | US5082659 Methods and compositions employing interferon-gamma |
| 01/21/1992 | US5082548 Separation, purification biomass |
| 01/21/1992 | CA1294736C Renin inhibitors containing 5-amino-2,5-disubstituted- 4-hydroxypentanoic acid residues |
| 01/20/1992 | WO1992001472A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2087541A1 Multivalent anti-cytokine immunoglobulins |
| 01/20/1992 | CA2047078A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047073A1 Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| 01/20/1992 | CA2047042A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047033A1 Cyclic hiv principal neutralizing determinant peptides |
| 01/20/1992 | CA2047031A1 Peptide-polysaccharide-protein conjugate vaccines |
| 01/20/1992 | CA2021591A1 Synthetic chondroitin sulfate proteoglycan and process for producing the same |
| 01/18/1992 | WO1992001781A1 Antibody-mediated cofactor-driven reactions |
| 01/18/1992 | CA2086755A1 Antibody-mediated cofactor-driven reactions |
| 01/17/1992 | WO1992001797A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 01/17/1992 | CA2084189A1 Immunoglobulin production by trichoderma |
| 01/17/1992 | CA2028526A1 Method for the purification of immunoreactive labeled thyroxine conjugates |
| 01/15/1992 | EP0466174A1 Novel physiologically active porcine peptide (CNP-53) |
| 01/15/1992 | EP0465895A1 WS7622A di- sulfate, process for preparation thereof and use thereof |
| 01/15/1992 | EP0465691A1 Apparatus for processing liquids |
| 01/15/1992 | EP0367795A4 Affinity separating using immobilized flocculating reagents |
| 01/15/1992 | CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
| 01/14/1992 | WO1992000998A1 Growth hormone crystals and a process for production of these gh-crystals |
| 01/14/1992 | US5081584 Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide |
| 01/14/1992 | US5081107 Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5081010 Alcoholamine, ethylene oxide alkylphenol compound; medical diagnosis |
| 01/14/1992 | CA1294233C Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
| 01/11/1992 | WO1992001055A1 O-glycosylated ifn-alpha |
| 01/11/1992 | CA2084514A1 O-glycosylated ifn-alpha |
| 01/09/1992 | WO1992000526A1 Peptide sequencing method and reagents therefor |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000317A1 Method and kit for the separation, concentration and analysis of cells |
| 01/09/1992 | WO1992000284A2 Method for forming an amino acid thiohydantoin using an n-substituted ketenimine activator |
| 01/09/1992 | WO1992000093A1 Transfer factor and methods of use |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | DE4021542A1 Combined process for prepn. of non-infectious blood plasma - comprises treating plasma with nonionic surfactants, adding lipid(s) to increase lipid phase and removing lipid phase and surfactants |
| 01/09/1992 | DE4014063A1 Dekontaminiertes biologisches material Decontaminated biological material |
| 01/09/1992 | CA2086610A1 Transfer factor and methods of use |